How do group purchasing organizations affect device pricing in this sector?

GPOs consolidate hospital buying power, compressing manufacturer margins by 8–15% on high-volume consumables [17]. Smaller OEMs face the steepest pressure because they lack the portfolio breadth to bundle contracts competitively. Read More

What training infrastructure gaps slow adoption of robotic urology platforms?

Most urology residency programs allocate fewer than 40 robotic-console hours per trainee annually [16]. This bottleneck limits utilization rates of installed systems and delays return-on-investment timelines for purchasing hospitals. Read More

How does the shift to value-based care reshape urology device procurement?

Hospitals increasingly evaluate devices on total episode-of-care cost rather than unit price alone—vendors offering outcomes-tracking dashboards and complication-reduction data gain preference under bundled-payment models [15]. Read More

What role do 3D-printed patient-specific models play in urologic surgery planning?

Surgeons use 3D-printed kidney and prostate replicas to rehearse complex tumor resections, reducing operative time by an estimated 12–18% in published case series [3]. Adoption remains limited to academic centers due to printing costs. Read More

How are cybersecurity mandates influencing connected urology device design?

The FDA's 2024 guidance requires SBOM disclosure and real-time threat monitoring for networked Class II and III devices [23]. Manufacturers must now embed security-by-design principles, adding 6–9 months to development timelines. Read More

Which reimbursement changes could accelerate home-based urologic care adoption?

CMS remote therapeutic monitoring codes (98975–98981) now cover select catheter-management and pelvic-floor therapy protocols [2]. Expanded code coverage would unlock recurring revenue for device firms offering connected home-use products. Read More

How do single-use ureteroscopes compare with reusable scopes on total procedural cost?

Per-procedure costs for single-use scopes have narrowed to within 10–15% of reusable alternatives when factoring in reprocessing, repair, and sterilization expenses [8]. Infection-rate reductions further close the gap on a total-value basis. Read More

Urology Devices Market (2026 - 2035)

ID: MRFR/HC/0614-HCR

200 Pages

Nidhi Mandole

Last Updated: July 22, 2026

Urology Devices Market Research Report By Product Type (Endoscopy Devices, Litotripters, Dialysis Equipment, Prostate Devices, Catheters), By Application (Diagnosis, Therapy, Surgery), By End User (Hospitals, Clinics, Home Care Settings), By Distribution Channel (Direct Sales, Distributors, Online Sales) and By Region (North America, Europe, South America, Asia Pacific, Middle East and Africa) -Forecast to 2035

Urology Devices Market

Market Size

Forecast Period2026-2035

CAGR (2026-2035)7.3%

2025 Market SizeUSD 42.20 Billion

2035 Market SizeUSD 85.30 Billion

Key Players

Boston Scientific

Medtronic

Becton Dickinson

Olympus Corporation

Coloplast

Siemens Healthineers

Trends

Rising Prevalence of Chronic Kidney Disease and Urolithiasis
Reimbursement and Regulatory Tailwinds
Single-Use Device Preference and Infection Control

Opportunities

Telehealth-Integrated Remote Patient Monitoring
Emerging-Market Infrastructure Build-Out
AI-Driven Diagnostic and Decision-Support Platforms

Summary Table of Contents Segmentation Methodology Download PDF

1 Market Overview |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Market Summary & Key Takeaways
3 Market Dynamics |
1. 3.1 Market Drivers Analysis | |
  1. 3.1.1 Rising Prevalence of Chronic Kidney Disease and Urolithiasis | |
  2. 3.1.2 Reimbursement and Regulatory Tailwinds | |
  3. 3.1.3 Robotic Surgery Platform Proliferation | |
  4. 3.1.4 Single-Use Device Preference and Infection Control | |
  5. 3.1.5 Aging Global Population | |
  6. 3.1.6 Ambulatory Surgical Center Expansion |
2. 3.2 Market Restraints Analysis | |
  1. 3.2.1 High Capital Costs of Robotic Platforms | |
  2. 3.2.2 Regulatory Complexity and Approval Timelines | |
  3. 3.2.3 Skilled-Operator Shortage | |
  4. 3.2.4 Reimbursement Compression in Mature Markets | |
  5. 3.2.5 Pricing Pressure from Group Purchasing Organizations |
3. 3.3 Market Opportunity Analysis | |
  1. 3.3.1 Telehealth-Integrated Remote Patient Monitoring | |
  2. 3.3.2 Emerging-Market Infrastructure Build-Out | |
  3. 3.3.3 AI-Driven Diagnostic and Decision-Support Platforms | |
  4. 3.3.4 Ambulatory Surgical Center Migration | |
  5. 3.3.5 Data Monetization and Outcomes Analytics |
4. 3.4 Industry Value Chain Analysis |
5. 3.5 Porter's Five Forces Analysis
4 Global Urology Devices Market Size & Forecast (2021–2035) |
1. 4.1 Historical Market Size (2021–2025) |
2. 4.2 Current & Forecast Market Size (2026–2035) |
3. 4.3 Market Size by Revenue (USD Billion) |
4. 4.4 Year-over-Year Growth Analysis
5 Segmentation Analysis |
1. 5.1 By Product | |
  1. 5.1.1 Instruments (Dialysis Devices and More) | |
  2. 5.1.2 Consumables & Accessories (Biopsy Devices and More) |
2. 5.2 By Technology | |
  1. 5.2.1 Minimally-Invasive Surgery Devices | |
  2. 5.2.2 Robotic Urologic Surgery Systems | |
  3. 5.2.3 Extracorporeal Shock-Wave Lithotripsy | |
  4. 5.2.4 Other Technologies |
3. 5.3 By Disease Indication | |
  1. 5.3.1 Kidney Diseases | |
  2. 5.3.2 Urinary Stones | |
  3. 5.3.3 Benign Prostatic Hyperplasia | |
  4. 5.3.4 Bladder Cancer | |
  5. 5.3.5 Other Diseases |
4. 5.4 By End User | |
  1. 5.4.1 Hospitals & Clinics | |
  2. 5.4.2 Dialysis Centres | |
  3. 5.4.3 Ambulatory Surgical Centers | |
  4. 5.4.4 Other End Users
6 Regional Analysis |
1. 6.1 North America | |
  1. 6.1.1 United States | |
  2. 6.1.2 Canada | |
  3. 6.1.3 Mexico |
2. 6.2 Europe | |
  1. 6.2.1 Germany | |
  2. 6.2.2 United Kingdom | |
  3. 6.2.3 France | |
  4. 6.2.4 Italy | |
  5. 6.2.5 Spain | |
  6. 6.2.6 Nordic Countries | |
  7. 6.2.7 Russia | |
  8. 6.2.8 Rest of Europe |
3. 6.3 Asia-Pacific | |
  1. 6.3.1 China | |
  2. 6.3.2 India | |
  3. 6.3.3 Japan | |
  4. 6.3.4 South Korea | |
  5. 6.3.5 ASEAN | |
  6. 6.3.6 Rest of Asia-Pacific |
4. 6.4 South America | |
  1. 6.4.1 Brazil | |
  2. 6.4.2 Argentina | |
  3. 6.4.3 Rest of South America |
5. 6.5 Middle East & Africa | |
  1. 6.5.1 Saudi Arabia | |
  2. 6.5.2 UAE | |
  3. 6.5.3 South Africa | |
  4. 6.5.4 Egypt | |
  5. 6.5.5 Rest of MEA
7 Competitive Landscape |
1. 7.1 Market Share Analysis (2025) |
2. 7.2 Competitive Benchmarking Matrix |
3. 7.3 Company Profiles | |
  1. 7.3.1 Boston Scientific | |
  2. 7.3.2 Medtronic | |
  3. 7.3.3 Becton Dickinson (BD) | |
  4. 7.3.4 Olympus Corporation | |
  5. 7.3.5 Coloplast | |
  6. 7.3.6 Siemens Healthineers | |
  7. 7.3.7 Stryker | |
  8. 7.3.8 Cook Medical | |
  9. 7.3.9 Karl Storz | |
  10. 7.3.10 Richard Wolf
8 Future Outlook & Strategic Recommendations (2026–2035) |
1. 8.1 AI-Augmented Surgical Navigation |
2. 8.2 Platform Economics and Ecosystem Lock-In |
3. 8.3 Sustainability and Circular-Economy Pressures |
4. 8.4 Decentralization of Urologic Care
9 Recent Developments & News
10 Frequently Asked Questions (FAQs)
11 Report Scope & Methodology |
1. 11.1 Study Period & Base Year |
2. 11.2 Data Sources & Citations |
3. 11.3 Abbreviations
12 LIST OF TABLES |
TABLE 1 Global Urology Devices Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
TABLE 2 Global Urology Devices Market – Year-over-Year Growth Analysis, 2021–2035 |
TABLE 3 Global Urology Devices Market – Driver Impact Analysis |
TABLE 4 Global Urology Devices Market – Restraint Impact Analysis |
TABLE 5 Global Urology Devices Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 6 Global Urology Devices Market Size, by Technology, 2021–2035 (USD Billion) |
TABLE 7 Global Urology Devices Market Size, by Disease Indication, 2021–2035 (USD Billion) |
TABLE 8 Global Urology Devices Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 9 Global Urology Devices Market Size, by Region, 2021–2035 (USD Billion) |
TABLE 10 North America Urology Devices Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 11 Europe Urology Devices Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 12 Asia-Pacific Urology Devices Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 13 South America Urology Devices Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 14 Middle East & Africa Urology Devices Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 15 Competitive Benchmarking Matrix – Global Urology Devices Market, 2025 |
TABLE 16 Company Profiles – Key Players, Global Urology Devices Market |
TABLE 17 Recent Developments & Strategic Announcements, 2023–2025 |
TABLE 18 Report Scope & Methodology Summary |
TABLE 19 Detailed Sources and Citations
13 LIST OF FIGURES |
FIGURE 1 Global Urology Devices Market Dynamics (Drivers, Restraints, Opportunities) |
FIGURE 2 Industry Value Chain Analysis – Urology Devices Market |
FIGURE 3 Porter's Five Forces Analysis – Urology Devices Market |
FIGURE 4 Global Urology Devices Market Size Trend (USD Billion), 2021–2035 |
FIGURE 5 Global Urology Devices Market Share, by Product (%), 2025 |
FIGURE 6 Global Urology Devices Market Share, by Technology (%), 2025 |
FIGURE 7 Global Urology Devices Market Share, by Disease Indication (%), 2025 |
FIGURE 8 Global Urology Devices Market Share, by End User (%), 2025 |
FIGURE 9 Global Urology Devices Market Share, by Region (%), 2025 |
FIGURE 10 North America Urology Devices Market Share, by Country (%), 2025 |
FIGURE 11 Europe Urology Devices Market Share, by Country (%), 2025 |
FIGURE 12 Asia-Pacific Urology Devices Market Share, by Country (%), 2025 |
FIGURE 13 South America Urology Devices Market Share, by Country (%), 2025 |
FIGURE 14 Middle East & Africa Urology Devices Market Share, by Country (%), 2025 |
FIGURE 15 Competitive Landscape – Revenue Share Analysis, 2025

Certified Researchers

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
By Product	Instruments (Dialysis Devices and More); Consumables & Accessories (Biopsy Devices and More)	Instruments	Consumables & Accessories
By Technology	Minimally-Invasive Surgery Devices; Robotic Urologic Surgery Systems; Extracorporeal Shock-Wave Lithotripsy; Other Technologies	Minimally-Invasive Surgery Devices	Robotic Urologic Surgery Systems
By Disease Indication	Kidney Diseases; Urinary Stones; Benign Prostatic Hyperplasia; Bladder Cancer; Other Diseases	Kidney Diseases	Urinary Stones
By End User	Hospitals & Clinics; Dialysis Centres; Ambulatory Surgical Centers; Other End Users	Hospitals & Clinics	Ambulatory Surgical Centers
By Region	North America; Europe; Asia-Pacific; South America; Middle East & Africa	North America	Asia-Pacific

Market Segmentation Overview

By Product

Sub-Segment	Key Trend
Instruments (Dialysis Devices and More)	Capital-equipment upgrade cycles driven by EU MDR compliance and robotic console replacements
Consumables & Accessories (Biopsy Devices and More)	Single-use scope adoption and rising per-procedure attachment rates lifting recurring revenue

The product dimension reflects a classical capital-versus-consumable revenue split. Instruments carry higher per-unit value but longer sales cycles, while consumables deliver predictable recurring revenue tied to procedure volumes.

By Technology

Sub-Segment	Key Trend
Minimally-Invasive Surgery Devices	Standard-of-care status across most urologic procedures, sustaining dominant share
Robotic Urologic Surgery Systems	Competitive multi-vendor landscape driving price declines and community-hospital penetration
Extracorporeal Shock-Wave Lithotripsy	Stable ambulatory-procedure base with incremental upgrades to electromagnetic generators
Other Technologies	Emerging AI-assisted diagnostic platforms and advanced urodynamic measurement tools

Technology segmentation captures the shift from open-surgery paradigms toward precision-guided, minimally-invasive, and robotic approaches that define the next decade of urologic care delivery.

By Disease Indication

Sub-Segment	Key Trend
Kidney Diseases	CKD prevalence growth sustaining demand for dialysis access devices and surgical instruments
Urinary Stones	Climate- and diet-linked incidence increases driving lithotripsy and ureteroscopy volumes
Benign Prostatic Hyperplasia	Office-based procedure migration with vapor-ablation and water-jet technologies
Bladder Cancer	Expanded screening guidelines increasing cystoscopy and resectoscopy utilization
Other Diseases	Incontinence management, pediatric urology, and urethral-disorder devices

Disease-indication segmentation reflects the epidemiological drivers that shape device demand independently of technology preferences or clinical-setting choices.

By End User

Sub-Segment	Key Trend
Hospitals & Clinics	Concentrated procedural volumes and capital budgets anchoring dominant share
Dialysis Centres	Standalone center expansion by DaVita, Fresenius, and regional chains
Ambulatory Surgical Centers	Payer incentives and patient preference accelerating outpatient procedure migration
Other End Users	Home-care monitoring and academic research institutions

End-user segmentation highlights the ongoing decentralization of urologic care from inpatient hospitals toward ambulatory and home-based settings, reshaping device design and distribution strategies.

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”